MEMBRANA GMBH – Trademark Portfolio
Entity Type: 03
MEMBRANA GMBH holds 26 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 18 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 5 Nice Classification classes. Currently, 12 trademarks are registered. Notable registered marks include HEXPET, PUREMA, ACCUREL, DURAPES, and OXYPHAN. The owner is based in WUPPERTAL.
OHDER STRASSE 28
WUPPERTAL D-42289 , DE
Showing of trademarks Trademarks
Trademark Classifications
MEMBRANA GMBH's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does MEMBRANA GMBH have?
MEMBRANA GMBH has 26 U.S. trademarks filed with the USPTO. Of these, 12 registered, 2 abandoned, 9 cancelled.
What trademark classes does MEMBRANA GMBH file in?
MEMBRANA GMBH files trademarks across 5 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 11 (Environmental Control), Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are MEMBRANA GMBH's most well-known trademarks?
MEMBRANA GMBH's registered trademark portfolio includes well-known marks such as HEXPET, PUREMA, ACCUREL, DURAPES, and OXYPHAN. These are among 12 currently registered trademarks in the portfolio.
What is MEMBRANA GMBH's trademark registration success rate?
MEMBRANA GMBH has a 52% trademark registration rate, with 12 out of 23 resolved applications resulting in successful registration. Currently, 0 applications are pending review.